Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer

被引:31
|
作者
Gyllensten, U. [1 ]
Sanner, K. [2 ]
Gustavsson, I. [1 ]
Lindell, M. [1 ]
Wikstrom, I. [2 ]
Wilander, E. [1 ]
机构
[1] Univ Uppsala Hosp, Dept Immunol Genet & Pathol, Rudbeck Lab, SciLifeLab, Uppsala, Sweden
[2] Uppsala Univ, Univ Uppsala Hosp, Dept Womens & Childrens Hlth, Uppsala, Sweden
关键词
cervix; screening; carcinoma; HPV test; persistence; self-sampling; HUMAN-PAPILLOMAVIRUS; WOMEN; PERSISTENCE; CLEARANCE; DEVICE; SWEDEN; COHORT; OLDER;
D O I
10.1038/bjc.2011.277
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Testing for high-risk human papillomavirus (HPV) in primary screening for cervical cancer is considered more sensitive, but less specific, in comparison with Pap-smear cytology. Women with persistent HPV infections have a higher risk of developing cervical intraepithelial neoplasia 2+ (CIN2+) lesions. This study was performed to evaluate the gain in specificity for detection of histologically confirmed CIN2+ lesions achieved by short-time repeat testing for high-risk HPV in women aged 30-65 years, with the primary sample for HPV analysis taken by self-sampling. METHODS: A total of 8000 women in Uppsala County, aged 30-65 years, who had not attended organised screening for 6 years or longer, were offered self-sampling of vaginal fluid at home and the samples sent for HPV typing. Of these, 8% (669) were not possible to contact or had performed hysterectomy. Women positive for high-risk HPV in the self-sampling test were invited for a follow-up HPV test and a cervical biopsy on average 3 months after the initial HPV test. RESULTS: In all, 39% (2850/7331) of invited women chose to perform self-sampling of vaginal fluid at home. High-risk HPV infection was found in 6.6% (188) of the women. In all, 89% of the women testing HPV positive performed a follow-up examination, on average 2.7 months, after the first test and 59% of these women were HPV positive in the follow-up test. The prevalence of CIN2+ lesions in women with an initial HPV-positive test was 23% (95% CI 18-30%) and in women with two consecutive HPV-positive tests was 41% (95% CI 31-51%). In women with two positive HPV tests, the prevalence of CIN2+ lesions varied from 49% in women at age 30-39 years to 24% in women at age 50-65 years. Short-time repeat HPV testing increased the specificity for detection of CIN2+ lesions from about 94.2% to 97.8%. The most prevalent HPV types were HPV16 (32%), followed by HPV18/45 (19%) and HPV 33/52/58 (19%). CONCLUSION: The short-time persistence of high-risk HPV infection in this age group was about 60%. Repeat testing for high-risk HPV using self-sampling of vaginal fluid can be used to increase the specificity in the screening for cervical cancer in women aged 30-65 years. British Journal of Cancer (2011) 105, 694-697. doi:10.1038/bjc.2011.277 www.bjcancer.com Published online 2 August 2011 (C) 2011 Cancer Research UK
引用
收藏
页码:694 / 697
页数:4
相关论文
共 50 条
  • [1] Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer
    U Gyllensten
    K Sanner
    I Gustavsson
    M Lindell
    I Wikström
    E Wilander
    [J]. British Journal of Cancer, 2011, 105 : 694 - 697
  • [2] Self-sampling for HPV testing in cervical cancer screening: A scoping review
    Colonetti, Tamy
    Uggioni, Maria Laura Rodrigues
    dos Santos, Ana Luiza Meller
    Uggioni, Naiade Michels
    Elibio, Laura Uggioni
    Balbinot, Eduarda Leticia
    Grande, Antonio Jose
    Rosa, Maria Ines
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 296 : 20 - 51
  • [3] Self-sampling HPV testing versus mainstream cervical screening and HPV testing
    Farnsworth, Annabelle
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2016, 204 (05) : 171 - +
  • [4] Is It Time to Introduce HPV Self-Sampling for Primary Cervical Cancer Screening?
    Petignat, Patrick
    Vassilakos, Pierre
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (03) : 166 - 167
  • [5] Self-sampling for high-risk human papillomavirus detection: future cervical cancer screening?
    Daponte, Alexandros
    Pournaras, Spyros
    Tsakris, Athanassios
    [J]. WOMENS HEALTH, 2014, 10 (02) : 115 - 118
  • [6] Utilization of self-sampling kits for HPV testing in cervical cancer screening - pilot study
    Ondryasova, H.
    Koudelakova, V
    Drabek, J.
    Vanek, P.
    Slavkovsky, R.
    Hajduch, M.
    [J]. CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, 2015, 80 (06): : 436 - 443
  • [7] Worldwide use of HPV self-sampling for cervical cancer screening
    Serrano, B.
    Ibanez, R.
    Robles, C.
    Peremiquel-Trillas, P.
    de Sanjose, S.
    Bruni, L.
    [J]. PREVENTIVE MEDICINE, 2022, 154
  • [8] Acceptability of Self-Sampling HPV Testing Among Thai Women for Cervical Cancer Screening
    Oranratanaphan, Shina
    Termrungruanglert, Wichai
    Khemapech, Nipon
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (17) : 7437 - 7441
  • [9] Self-sampling of the vaginal fluid at home combined with high-risk HPV testing
    K Sanner
    I Wikström
    A Strand
    M Lindell
    E Wilander
    [J]. British Journal of Cancer, 2009, 101 : 871 - 874
  • [10] Self-sampling of the vaginal fluid at home combined with high-risk HPV testing
    Sanner, K.
    Wikstrom, I.
    Strand, A.
    Lindell, M.
    Wilander, E.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 (05) : 871 - 874